Correlation Between Evoke Pharma and Nabriva Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Evoke Pharma and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Nabriva Therapeutics.

Diversification Opportunities for Evoke Pharma and Nabriva Therapeutics

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Evoke and Nabriva is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Nabriva Therapeutics go up and down completely randomly.

Pair Corralation between Evoke Pharma and Nabriva Therapeutics

If you would invest  162.00  in Nabriva Therapeutics AG on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Nabriva Therapeutics AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.53%
ValuesDaily Returns

Evoke Pharma  vs.  Nabriva Therapeutics AG

 Performance 
       Timeline  
Evoke Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Evoke Pharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.
Nabriva Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nabriva Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nabriva Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Evoke Pharma and Nabriva Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evoke Pharma and Nabriva Therapeutics

The main advantage of trading using opposite Evoke Pharma and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.
The idea behind Evoke Pharma and Nabriva Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum